Down regulation of the expression of mitochondrial phosphopantetheinyl-proteins in pantothenate kinase-associated neurodegeneration: pathophysiological consequences and therapeutic perspectives.
Mónica Álvarez-CórdobaMarta Talaverón-ReyIrene Villalón-GarcíaSuleva Povea-CabelloJuan M Suárez-RiveroAlejandra Suárez-CarrilloManuel Munuera-CabezaJoaquín J SalasJosé Antonio Sánchez-AlcázarPublished in: Orphanet journal of rare diseases (2021)
Our results suggest that the expression levels of mitochondrial phosphopantetheinyl-proteins are severely reduced in PKAN cells and that in selected mutations pantothenate increases the expression levels of both PANK2 and mitochondrial phosphopantetheinyl-proteins associated with remarkable improvement of cell pathophysiology.